Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Published Oct 31, 2020

The Promise — and Perils — of CAR T-Cell Therapy

×
NOW
PLAYING
Fans Pray For Radio Host Dan Bongino After Finishing Cancer treatment
NOW
PLAYING
Are Swollen Lymph Nodes After a COVID-19 Vaccine Dangerous? Absolutely Not
NOW
PLAYING
Can You Get Chemotherapy for Cancer at Home? The New Push During COVID-19
NOW
PLAYING
The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation--Extraordinary Results With Sotorasib
NOW
PLAYING
Leukemia Survivor Says Symptoms Were First Dismissed as “Teen Hormones” & Now Has Early Menopause from Treatment; “I Kept Getting Told to Change My Lifestyle”
NOW
PLAYING
ABC's Remarkably Brave Robin Roberts Looks Towards A Brighter Future Nine Years After Bone Marrow Transplant: "This Too Shall Pass"

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.